Title : Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease - Xiang_2012_J.Pharmacol.Exp.Ther_340_595 |
Author(s) : Xiang Z , Thompson AD , Jones CK , Lindsley CW , Conn PJ |
Ref : Journal of Pharmacology & Experimental Therapeutics , 340 :595 , 2012 |
Abstract : Xiang_2012_J.Pharmacol.Exp.Ther_340_595 |
ESTHER : Xiang_2012_J.Pharmacol.Exp.Ther_340_595 |
PubMedSearch : Xiang_2012_J.Pharmacol.Exp.Ther_340_595 |
PubMedID: 22135383 |
Title : The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease - Jones_2012_J.Pharmacol.Exp.Ther_340_404 |
Author(s) : Jones CK , Bubser M , Thompson AD , Dickerson JW , Turle-Lorenzo N , Amalric M , Blobaum AL , Bridges TM , Morrison RD , Jadhav S , Engers DW , Italiano K , Bode J , Daniels JS , Lindsley CW , Hopkins CR , Conn PJ , Niswender CM |
Ref : Journal of Pharmacology & Experimental Therapeutics , 340 :404 , 2012 |
Abstract : Jones_2012_J.Pharmacol.Exp.Ther_340_404 |
ESTHER : Jones_2012_J.Pharmacol.Exp.Ther_340_404 |
PubMedSearch : Jones_2012_J.Pharmacol.Exp.Ther_340_404 |
PubMedID: 22088953 |
Title : Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats - Brady_2008_J.Pharmacol.Exp.Ther_327_941 |
Author(s) : Brady AE , Jones CK , Bridges TM , Kennedy JP , Thompson AD , Heiman JU , Breininger ML , Gentry PR , Yin H , Jadhav SB , Shirey JK , Conn PJ , Lindsley CW |
Ref : Journal of Pharmacology & Experimental Therapeutics , 327 :941 , 2008 |
Abstract : Brady_2008_J.Pharmacol.Exp.Ther_327_941 |
ESTHER : Brady_2008_J.Pharmacol.Exp.Ther_327_941 |
PubMedSearch : Brady_2008_J.Pharmacol.Exp.Ther_327_941 |
PubMedID: 18772318 |